Will the FDA New Flavored Vape Guidance Change PMTA Reviews?

The U.S. Food and Drug Administration has proposed new guidance explaining how it may evaluate youth risks and adult benefits when reviewing premarket applications for flavored electronic cigarettes.

The draft suggests that non-tobacco flavors should not always be treated as presenting identical levels of youth appeal. Products using flavors such as mint, coffee, tea or spices may have a different risk profile from fruit, candy, dessert or other sweet-flavored products.

This could create a clearer path for some flavored products seeking authorization through the Premarket Tobacco Product Application process.

However, the guidance does not establish a simple approval formula. Manufacturers must still submit product-specific scientific evidence demonstrating that marketing a product would be appropriate for the protection of public health.

For small and independent vape companies, that evidentiary burden may remain the biggest obstacle.

Complete List of FDA Authorized Vapes in 2026

What Is the FDA’s New Flavored Vape Guidance?

On March 11, 2026, the FDA published a draft document titled:

Flavored Electronic Nicotine Delivery Systems Premarket Applications—Considerations Related to Youth Risk.

The guidance is intended to assist manufacturers submitting PMTAs for flavored electronic nicotine delivery system products.

Its main objectives are to explain:

• How the FDA may compare youth risks across flavor categories
• What evidence may demonstrate that a flavor is oriented toward adults
• How manufacturers can evaluate youth appeal
• What adult switching benefits may be relevant
• How the FDA balances product risks and benefits
• Which study designs may strengthen an application

The draft was published under docket number FDA-2026-D-1817.

The 60-day public comment period closed on May 11, 2026. As of July 2026, the FDA document remains draft guidance rather than a binding final rule. Federal Register notice

Featured Snippet Answer

Will the FDA’s flavored vape guidance make flavor authorization easier?

Possibly, but not automatically. The draft recognizes that some non-tobacco flavors may present lower youth appeal than fruit, candy or dessert flavors. Manufacturers must still provide product-specific evidence showing that adult benefits outweigh youth risks under the APPH standard.

What Is the APPH Standard?

APPH means “appropriate for the protection of the public health.”

This is the legal standard the FDA applies when reviewing a PMTA for a new tobacco product.

The agency considers the risks and benefits to the population as a whole, including:

• Adults who currently smoke
• Adults who may switch completely
• People who use both cigarettes and vapes
• Former tobacco users
• People who do not currently use tobacco
• Children and young people

For an electronic cigarette to meet the APPH standard, the FDA must determine that its expected public-health benefits outweigh its expected risks.

Potential benefits may include:

• Helping adult smokers switch completely from cigarettes
• Increasing smoking quit attempts
• Supporting continued cigarette abstinence
• Reducing cigarette consumption
• Providing an alternative for adults who would otherwise continue smoking

Potential risks may include:

• Youth initiation
• Nicotine dependence among non-smokers
• Dual use
• Relapse among former tobacco users
• Misleading marketing
• Increased exposure to flavored nicotine products

Why Do Flavored Products Face a Higher Evidentiary Burden?

The FDA has historically treated non-tobacco flavors as creating additional youth-appeal concerns.

A manufacturer seeking authorization for a flavored product must generally demonstrate more than product chemistry and basic safety information. It must also show that the expected benefits for adults who smoke are sufficient to outweigh the potential risks to young people.

The FDA has previously described product-specific randomized controlled trials and longitudinal cohort studies as examples of evidence that may demonstrate adult-use benefits.

These studies can be expensive and time-consuming.

A comprehensive application may need to examine:

• Complete switching from cigarettes
• Reduction in cigarette consumption
• Sustained cigarette abstinence
• Flavor preferences
• Youth appeal
• Adult appeal
• Product-use patterns
• Nicotine exposure
• Marketing effects
• Risk perceptions
• Likelihood of non-smoker uptake

Large tobacco companies may have the resources to conduct this work. Smaller e-liquid and hardware manufacturers may struggle to finance studies at the same scale.

Does the Guidance Create Different Flavor Categories?

The draft moves toward a more risk-proportionate analysis of flavors.

It identifies fruit and candy, dessert or other sweet flavors as categories associated with substantial youth-use concerns.

At the same time, the FDA acknowledges that other categories may show lower youth appeal in available evidence.

Examples discussed in the draft include:

• Mint
• Coffee
• Tea
• Spice flavors

This does not mean these flavors are presumed safe or guaranteed authorization. It means the FDA may evaluate their youth-risk profile differently from products marketed as candy, dessert or sweet fruit.

Which Flavors May Have a Clearer Path?

The draft suggests that products with evidence of relatively low youth appeal may face a lower youth-risk burden than highly youth-attractive categories.

A possible risk framework would look like this:

The categories do not function as formal approval tiers. Every application remains product-specific.

Is the Draft Guidance Legally Binding?

No.

FDA guidance describes the agency’s current thinking. It is not the same as:

• A federal statute
• A regulation
• A product standard
• A marketing authorization
• A legally guaranteed approval pathway

The draft explicitly states that its recommendations are nonbinding.

Manufacturers may use an alternative approach if that approach satisfies the applicable laws and regulations. Likewise, following every recommendation in the document does not guarantee that the FDA will authorize the product.

Guidance Versus Regulation

This distinction matters for manufacturers making investment decisions.

The guidance may improve transparency, but it does not provide numerical benchmarks that guarantee authorization.

Does Following the Guidance Guarantee a Successful PMTA?

No.

A manufacturer could follow the draft guidance and still receive a marketing denial order.

The FDA will continue evaluating:

• The complete application
• Product formulation
• Aerosol constituents
• Toxicology
• Manufacturing controls
• Nicotine delivery
• Adult-use benefits
• Youth initiation risks
• Marketing plans
• Postmarket controls
• Population-level effects

A coffee-flavored product does not qualify merely because “coffee” appears among the categories that may have lower youth appeal.

The applicant must demonstrate that the specific product—using its actual name, packaging, nicotine level, design and marketing plan—meets the APPH standard.

What Evidence Could Demonstrate Lower Youth Appeal?

The draft discusses several forms of evidence that may help characterize a product’s appeal and intended audience.

These could include:

• Youth and adult perception studies
• Flavor-preference surveys
• Behavioural choice experiments
• Product-name testing
• Packaging research
• Purchase-intention studies
• Actual-use studies
• Market data
• Longitudinal research
• Randomized studies
• Comparisons with tobacco-flavored products

A manufacturer might need to demonstrate that:

• Adults who smoke find the product acceptable.
• Youth show relatively low interest in the flavor.
• Packaging does not use youth-oriented imagery.
• The product name avoids sweets, cartoons or entertainment themes.
• Advertising reaches adults rather than underage audiences.
• The product supports switching away from cigarettes.

Why Survey Data Alone May Not Be Enough

The FDA notes that apparently low youth use of coffee, tea or spice flavors may reflect factors other than reduced appeal.

For example:

• Few products in those flavors may be available.
• Surveys may not list every flavor category.
• Respondents may classify the same flavor differently.
• Products may have limited distribution.
• The survey sample may be too small.
• The flavor may be marketed under an unclear name.
• Youth may use mixed flavors that do not fit one category.

A low survey prevalence does not necessarily prove that a flavor would remain unattractive if widely marketed.

Manufacturers may therefore need product-specific evidence rather than relying only on national survey results.

Have Any Non-Tobacco, Non-Menthol Vapes Been Authorized?

Yes.

Earlier commentary on the guidance stated that no non-tobacco, non-menthol ENDS product had successfully completed the PMTA process. That statement became outdated on May 5, 2026.

The FDA authorized four additional Glas G2 pods:

• Classic Menthol 50 mg/mL
• Fresh Menthol 50 mg/mL
• Gold 50 mg/mL
• Sapphire 50 mg/mL

The FDA described Gold and Sapphire as the first authorized ENDS products with flavors other than tobacco or menthol.

These authorizations increased the FDA’s authorized e-cigarette list to 45 product records.

Why Were the Glas Products Authorized?

The Glas authorization relied partly on device-level age-verification technology.

The system requires a user to:

1. Verify age and identity with government-issued identification.
2. Pair the Glas G2 device with a smartphone.
3. Keep the verified phone near the device.
4. Complete random biometric checks.

According to the FDA, the applicant provided evidence that adults aged 21 and older could use the verification system while youth and young adults were unable to complete the process successfully.

The agency concluded that these safeguards were expected to reduce youth access sufficiently for the expected adult benefits to outweigh the risks.

This does not establish a general right to market fruit-flavored products. The orders apply only to the four specific pods reviewed by the FDA. FDA Glas authorization

Did the Guidance Lead to the Glas Authorization?

The timing is relevant, but the guidance itself did not authorize the Glas products.

A draft guidance cannot replace the PMTA review process. The Glas applications were evaluated on their own scientific record, product design and proposed safeguards.

The decision does, however, demonstrate several principles reflected in the draft:

• Non-tobacco flavors are not categorically barred from authorization.
• Youth risk can potentially be addressed through technology.
• Product-specific evidence remains essential.
• The FDA may consider adult switching benefits.
• Marketing restrictions can be part of an authorization.
• Authorization remains limited to the reviewed SKUs.

Does the Glas Decision Help Small Manufacturers?

Only to a limited extent.

The decision proves that authorization of a non-tobacco, non-menthol flavor is possible. It does not necessarily create an affordable pathway for small manufacturers.

The Glas model involved:

• Government-ID verification
• Smartphone pairing
• Bluetooth controls
• Biometric checks
• Adult-targeted marketing
• Postmarket reporting
• Product-specific scientific evidence

Developing, validating and maintaining those systems may require substantial investment.

Traditional open-system e-liquids and devices cannot easily adopt the same closed-device access controls.

Does the Guidance Establish Product Standards?

No.

A product standard could establish measurable requirements such as:

• Maximum nicotine concentration
• Permitted ingredients
• Prohibited flavor compounds
• Emissions limits
• Manufacturing specifications
• Mandatory age-gating
• Packaging requirements
• Device-locking technology

The flavored ENDS guidance does none of these things.

It does not specify:

• A maximum acceptable youth-appeal score
• A required adult-switching percentage
• A standard clinical-trial design
• A guaranteed list of acceptable flavors
• A maximum nicotine strength
• A fixed PMTA review timeline
• A cost-effective route for small businesses

Manufacturers must still interpret the FDA’s recommendations and determine what evidence may be sufficient.

How Long Can a Flavored PMTA Take?

The theoretical statutory review framework and the actual time required are not always the same.

An application may face:

• Initial filing review
• Acceptance review
• Substantive scientific review
• Requests for additional information
• Environmental review
• Marketing-plan review
• Product-specific deficiency letters
• Administrative appeals
• Litigation
• Remand to the FDA

Complex applications can remain unresolved for years.

The draft guidance may make applications more complete, but it does not guarantee a shorter review period.

Do Flavors Influence Youth Vaping?

The relationship between flavors and youth vaping is more complicated than either side of the debate sometimes suggests.

Flavor availability may influence:

• Product experimentation
• Product appeal
• Continued use
• Brand choice
• Perceived harm
• Willingness to try nicotine

Other important factors include:

• Peer behaviour
• Product availability
• Price
• Device design
• Social media
• Nicotine strength
• Concealability
• Enforcement
• Age verification
• Risk perception

U.S. youth vaping has fallen substantially from its 2019 peak even though flavored products remain widely available through unauthorized channels.

That trend shows that flavor availability alone does not explain every change in youth use. It does not prove that flavors have no influence.

A scientifically careful conclusion is that youth vaping is shaped by multiple factors, with flavor being one relevant variable among several.

Why Adult Flavor Preferences Matter

The FDA’s Federal Register notice acknowledges that many adults who use vaping products to move away from cigarettes report a preference for non-tobacco flavors.

Non-tobacco flavors may help some adult smokers:

• Separate vaping from the taste of cigarettes
• Find a satisfying alternative
• Avoid returning to smoking
• Continue using a noncombustible product
• Transition away from tobacco flavors over time

Authorization depends on whether the overall evidence supports a net public-health benefit.

Could Mint, Coffee or Tea Products Be Authorized Next?

They may have a more plausible pathway, but authorization is not guaranteed.

A strong application could combine:

• Evidence of low youth interest
• Evidence of adult smoker preference
• Complete-switching data
• Restricted product names
• Adult-oriented packaging
• Strong retail age verification
• Digital access controls
• Carefully targeted advertising
• Postmarket surveillance

The FDA may still deny the application if evidence of adult benefit is weak or if youth safeguards are insufficient.

What Does the Guidance Mean for Open-System Products?

The implications for bottled e-liquid and open-system products remain uncertain.

As of July 2026, the FDA’s authorized ENDS list does not include conventional bottled e-liquid or traditional open-system vape-shop hardware.

Open-system products present several regulatory challenges:

• Users can combine hardware and liquids from different companies.
• Devices may operate at different power levels.
• Emissions can vary according to settings.
• Age-gating cannot always be built into the liquid.
• Product configurations are difficult to define.
• Each flavor and strength may require separate evidence.

The draft guidance does not solve these structural issues.

What Manufacturers Should Do

Identify the Exact Flavor Category

Manufacturers should avoid assuming a flavor is “adult-oriented” without supporting evidence.

Test the Full Product Presentation

Youth appeal may be affected by:

• Product name
• Package color
• Graphics
• Device appearance
• Social-media content
• Flavor description

Measure Adult Switching

Applications should focus on complete replacement of cigarettes, not merely trial or dual use.

Build Youth Controls Into the Product

The Glas decision suggests that validated access-control technology may materially strengthen an application.

Prepare Product-Specific Evidence

General literature on coffee or mint flavor is unlikely to replace data about the actual product.

Budget for Postmarket Monitoring

Authorization may require continued reporting on youth use, marketing audiences and product-use patterns.

What Retailers Should Understand

The draft guidance does not make currently unauthorized coffee-, mint-, tea- or spice-flavored products legal.

A product remains unauthorized unless the FDA issues a written marketing order.

Retailers should not accept claims such as:

• “Complies with the new flavor guidance”
• “FDA-friendly flavor”
• “Likely to be approved”
• “Lower-youth-risk category”
• “PMTA submitted under new guidance”

None of these phrases proves that the product may lawfully be sold.

Frequently Asked Questions

Is the FDA’s flavored vape guidance final?

No. It was issued as draft guidance on March 11, 2026. The formal 60-day comment period closed on May 11.

Is the guidance legally binding?

No. Guidance explains the FDA’s current thinking and recommendations. It does not create binding product standards.

Does the guidance make flavored vapes legal?

No. Each new product still requires a written FDA marketing order.

Which flavors may face lower youth-risk concerns?

The FDA discusses categories such as mint, coffee, tea and spice as potentially presenting different youth-appeal profiles from fruit, candy, dessert and other sweet flavors.

Are coffee-flavored vapes guaranteed authorization?

No. Manufacturers must submit product-specific evidence showing that expected adult benefits outweigh youth risks.

Has the FDA authorized fruit-flavored vapes?

Yes. In May 2026, it authorized Glas G2 Gold and Sapphire pods, describing them as the first non-tobacco, non-menthol authorized ENDS products.

Does the Glas decision apply to every fruit flavor?

No. It applies only to the specific Glas products covered by the marketing orders.

Are bottled e-liquids FDA-authorized?

No conventional bottled e-liquids appear on the FDA’s current authorized ENDS list.

Can a pending PMTA product be legally sold?

A pending application is not a marketing authorization. The FDA states that new tobacco products need a written marketing order to be legally marketed.

Will the guidance reduce PMTA costs?

It may clarify what evidence the FDA considers relevant, but it does not eliminate the need for potentially costly scientific studies.

Final Conclusion

The FDA’s 2026 flavored ENDS guidance represents a meaningful change in tone, but not a simple route to market.

The draft acknowledges that non-tobacco flavors may differ in youth appeal and that some flavors—such as mint, coffee, tea and spice—may deserve a more proportionate, product-specific review.

The Glas G2 authorization also demonstrates that non-tobacco, non-menthol products can receive marketing orders when an applicant presents sufficient adult-benefit evidence and strong youth-access controls.

However, the central PMTA challenge remains. Manufacturers must still demonstrate that their specific products provide a net public-health benefit under the APPH standard. The guidance supplies considerations, not guaranteed benchmarks.

For large companies with research budgets and proprietary age-verification technology, the path may now be clearer. For small manufacturers of bottled e-liquid and open-system products, it may remain financially and scientifically difficult.

The draft could change how the FDA reviews flavored products. Whether it creates a genuinely broader legal market will depend on the final guidance, future PMTA decisions and whether the agency develops standards that companies of different sizes can realistically meet.

Compliance disclaimer: This article provides general regulatory information and does not constitute legal advice. Manufacturers and retailers should verify product status through the FDA’s official database.